Exchange Bulletin
The Hydropothecary Corporation (HEXO, HEXO.WT) To Trade On Toronto Stock Exchange
Issuer: | The Hydropothecary Corporation ("Hydropothecary") |
Common Shares | |
Security: | Common shares (the "Shares") |
Symbol: | HEXO |
Number of securities issued and outstanding: | 191,560,223 Shares |
Number of securities reserved for issuance: | 47,188,147 Shares |
Trading currency: | CDN$ |
Listing date: | June 22, 2018 (at the opening) |
Posted for trading date: | June 22, 2018 (at the opening) |
Warrants | |
Security: | Share purchase warrants (the "Warrants") |
Symbol: | HEXO.WT |
Exercise price: | $5.60 per Share |
Expiry: | 5:00 p.m. (Eastern time) on January 30, 2020 |
Number of securities issued and outstanding: | 18,577,500 Warrants |
Number of securities reserved for issuance: | Nil |
Trading currency: | CDN$ |
Listing date: | June 22, 2018 (at the opening) |
Posted for trading date: | June 22, 2018 (at the opening) |
Other Information | |
Listing category: | Industrial, Non-Exempt Issuer |
Other market(s): | The Shares have been listed and trading on TSX Venture Exchange since March 21, 2017 under the symbol "THCX" and the Warrants under the symbol THCX.WT since February 2, 2018. The Shares and Warrants will be delisted from TSX Venture Exchange on June 22, 2018, upon commencement of trading on Toronto Stock Exchange. Upon listing on Toronto Stock Exchange, the Shares and Warrants will be traded under the new symbols "HEXO" and "HEXO.WT", respectively. |
Temporary market maker: | Citadel Securities Canada ULC |
Security ownership registration: | Shares: Certificated IssueWarrants: Uncertificated Issue – Non-Certificated Inventory |
Investor relations: | Ms. Jennifer Smith (819) 742-0111, ext. 104 Email: jennifer.smith@thehydropothecary.com Mr. Ed Chaplin (613) 852-9372 Email: ed.chaplin@thehydropothecary.com |
Incorporation: | Business Corporations Act (Ontario) |
Fiscal year end: | July 31 |
Nature of business: | Hydropothecary creates and distributes innovative, easy to use and easy to understand products under Health Canada's Access to Cannabis for Medical Purposes Regulations. |
Transfer agent and registrar: | TSX Trust Company at its principal offices in Toronto |
Dividends: | None anticipated in the foreseeable future |
Sponsorship: | Not applicable |
Disclosure document: | Annual Information Form dated November 8, 2017 which is available at www.SEDAR.com. Capitalized terms not otherwise defined herein are as defined in the disclosure document. |
Additional information: | Warrant indenture dated January 30, 2018 between Hydropothecary and TSX Trust Company |
TSX contact: | Julie K. Shin, Director, Listed Issuer Services, Toronto Stock Exchange |